These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 33799642)
1. Photoinactivation of Staphylococci with 405 nm Light in a Trachea Model with Saliva Substitute at 37 °C. Meurle T; Knaus J; Barbano A; Hoenes K; Spellerberg B; Hessling M Healthcare (Basel); 2021 Mar; 9(3):. PubMed ID: 33799642 [TBL] [Abstract][Full Text] [Related]
2. Inactivation Effect of Violet and Blue Light on ESKAPE Pathogens and Closely Related Non-pathogenic Bacterial Species - A Promising Tool Against Antibiotic-Sensitive and Antibiotic-Resistant Microorganisms. Hoenes K; Bauer R; Meurle T; Spellerberg B; Hessling M Front Microbiol; 2020; 11():612367. PubMed ID: 33519770 [TBL] [Abstract][Full Text] [Related]
3. Investigation on Potential ESKAPE Surrogates for 222 and 254 nm Irradiation Experiments. Gierke AM; Hessling M Front Microbiol; 2022; 13():942708. PubMed ID: 35847114 [TBL] [Abstract][Full Text] [Related]
4. Characterizing the Antimicrobial Properties of 405 nm Light and the Corning® Light-Diffusing Fiber Delivery System. Shehatou C; Logunov SL; Dunman PM; Haidaris CG; Klubben WS Lasers Surg Med; 2019 Dec; 51(10):887-896. PubMed ID: 31302937 [TBL] [Abstract][Full Text] [Related]
5. Alternatives for the treatment of infections caused by ESKAPE pathogens. da Rosa TF; Coelho SS; Foletto VS; Bottega A; Serafin MB; Machado CS; Franco LN; de Paula BR; Hörner R J Clin Pharm Ther; 2020 Aug; 45(4):863-873. PubMed ID: 32339305 [TBL] [Abstract][Full Text] [Related]
8. Clonal dispersion of Acinetobacter baumannii in an intensive care unit designed to patients COVID-19. Durán-Manuel EM; Cruz-Cruz C; Ibáñez-Cervantes G; Bravata-Alcantará JC; Sosa-Hernández O; Delgado-Balbuena L; León-García G; Cortés-Ortíz IA; Cureño-Díaz MA; Castro-Escarpulli G; Vélez-Reséndiz JM; Bello-López JM J Infect Dev Ctries; 2021 Jan; 15(1):58-68. PubMed ID: 33571146 [TBL] [Abstract][Full Text] [Related]
9. The utility of endotracheal aspirate bacteriology in identifying mechanically ventilated patients at risk for ventilator associated pneumonia: a single-center prospective observational study. Kabak E; Hudcova J; Magyarics Z; Stulik L; Goggin M; Szijártó V; Nagy E; Stevens C BMC Infect Dis; 2019 Aug; 19(1):756. PubMed ID: 31464593 [TBL] [Abstract][Full Text] [Related]
10. Differential anti-microbial secondary metabolites in different ESKAPE pathogens explain their adaptation in the hospital setup. Tiwari V; Meena K; Tiwari M Infect Genet Evol; 2018 Dec; 66():57-65. PubMed ID: 30227225 [TBL] [Abstract][Full Text] [Related]
11. The efficiency of routine endotracheal aspirate cultures compared to bronchoalveolar lavage cultures in ventilator-associated pneumonia diagnosis. Yagmurdur H; Tezcan AH; Karakurt O; Leblebici F Niger J Clin Pract; 2016; 19(1):46-51. PubMed ID: 26755218 [TBL] [Abstract][Full Text] [Related]
12. Norfloxacin salts of carboxylic acids curtail planktonic and biofilm mode of growth in ESKAPE pathogens. Lowrence RC; Ramakrishnan A; Sundaramoorthy NS; Shyam A; Mohan V; Subbarao HMV; Ulaganathan V; Raman T; Solomon A; Nagarajan S J Appl Microbiol; 2018 Feb; 124(2):408-422. PubMed ID: 29178633 [TBL] [Abstract][Full Text] [Related]
13. Ventilator-associated pneumonia: role of colonizers and value of routine endotracheal aspirate cultures. Joseph NM; Sistla S; Dutta TK; Badhe AS; Parija SC Int J Infect Dis; 2010 Aug; 14(8):e723-9. PubMed ID: 20542716 [TBL] [Abstract][Full Text] [Related]
14. Fluorescence High-Throughput Screening for Inhibitors of TonB Action. Nairn BL; Eliasson OS; Hyder DR; Long NJ; Majumdar A; Chakravorty S; McDonald P; Roy A; Newton SM; Klebba PE J Bacteriol; 2017 May; 199(10):. PubMed ID: 28242720 [TBL] [Abstract][Full Text] [Related]
15. [The changing patterns and the associated factors of microbial pathogens in ventilator-associated pneumonia in a respiratory intensive care unit from 1995 to 2004]. Yang W; He B; Zhao MW Zhonghua Jie He He Hu Xi Za Zhi; 2008 Aug; 31(8):598-602. PubMed ID: 19080406 [TBL] [Abstract][Full Text] [Related]
16. Detection of ESKAPE Bacterial Pathogens at the Point of Care Using Isothermal DNA-Based Assays in a Portable Degas-Actuated Microfluidic Diagnostic Assay Platform. Renner LD; Zan J; Hu LI; Martinez M; Resto PJ; Siegel AC; Torres C; Hall SB; Slezak TR; Nguyen TH; Weibel DB Appl Environ Microbiol; 2017 Feb; 83(4):. PubMed ID: 27986722 [TBL] [Abstract][Full Text] [Related]
17. Bacteremia due to ESKAPE pathogens: An emerging problem in cancer patients. El-Mahallawy HA; Hassan SS; El-Wakil M; Moneer MM J Egypt Natl Canc Inst; 2016 Sep; 28(3):157-62. PubMed ID: 27268592 [TBL] [Abstract][Full Text] [Related]
18. Epidemiology of Ventilator-Associated Pneumonia, microbiological diagnostics and the length of antimicrobial treatment in the Polish Intensive Care Units in the years 2013-2015. Wałaszek M; Różańska A; Wałaszek MZ; Wójkowska-Mach J; BMC Infect Dis; 2018 Jul; 18(1):308. PubMed ID: 29976151 [TBL] [Abstract][Full Text] [Related]
19. Characterisation and evaluation of novel surfactant bacterial anti-adherent coatings for endotracheal tubes designed for the prevention of ventilator-associated pneumonia. Jones DS; McMeel S; Adair CG; Gorman SP J Pharm Pharmacol; 2003 Jan; 55(1):43-52. PubMed ID: 12625866 [TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity of medicinal plants against ESKAPE: An update. Bhatia P; Sharma A; George AJ; Anvitha D; Kumar P; Dwivedi VP; Chandra NS Heliyon; 2021 Feb; 7(2):e06310. PubMed ID: 33718642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]